These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30352204)

  • 1. Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis.
    Conklin LS; Merkel PA; Pachman LM; Parikh H; Tawalbeh S; Damsker JM; Cuthbertson DD; Morgan GA; Monach PA; Hathout Y; Nagaraju K; van den Anker J; McAlear CA; Hoffman EP
    Steroids; 2018 Dec; 140():159-166. PubMed ID: 30352204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.
    Ishizaki J; Takemori A; Suemori K; Matsumoto T; Akita Y; Sada KE; Yuzawa Y; Amano K; Takasaki Y; Harigai M; Arimura Y; Makino H; Yasukawa M; Takemori N; Hasegawa H;
    Arthritis Res Ther; 2017 Sep; 19(1):218. PubMed ID: 28962592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
    Pepper RJ; McAdoo SP; Moran SM; Kelly D; Scott J; Hamour S; Burns A; Griffith M; Galliford J; Levy JB; Cairns TD; Gopaluni S; Jones RB; Jayne D; Little MA; Pusey CD; Salama AD
    Rheumatology (Oxford); 2019 Feb; 58(2):260-268. PubMed ID: 30239910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Robson JC; Dawson J; Cronholm PF; Ashdown S; Easley E; Kellom KS; Gebhart D; Lanier G; Milman N; Peck J; Luqmani RA; Shea JA; Tomasson G; Merkel PA
    Rheumatol Int; 2018 Apr; 38(4):675-682. PubMed ID: 29124398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis.
    Monach PA; Warner RL; Tomasson G; Specks U; Stone JH; Ding L; Fervenza FC; Fessler BJ; Hoffman GS; Iklé D; Kallenberg CG; Krischer J; Langford CA; Mueller M; Seo P; St Clair EW; Spiera R; Tchao N; Ytterberg SR; Johnson KJ; Merkel PA
    Ann Rheum Dis; 2013 Aug; 72(8):1342-50. PubMed ID: 22975753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study.
    Wen R; Xiao J; Ding N; Zhong Y; Yuan Q; Li J; Wang Q; Xie H; Qin J
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1061-1072. PubMed ID: 38536523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
    Jayne D; Blockmans D; Luqmani R; Moiseev S; Ji B; Green Y; Hall L; Roth D; Henderson RB; Merkel PA;
    Arthritis Rheumatol; 2019 Jun; 71(6):952-963. PubMed ID: 30666823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Pepper RJ; Draibe JB; Caplin B; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; Monach PA; Seo P; Spiera R; William St Clair E; Tchao NK; Stone JH; Specks U; Merkel PA; Salama AD;
    Arthritis Rheumatol; 2017 Jan; 69(1):185-193. PubMed ID: 27428710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
    Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
    Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
    Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
    Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.
    Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V
    Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.
    Monach PA; Tomasson G; Specks U; Stone JH; Cuthbertson D; Krischer J; Ding L; Fervenza FC; Fessler BJ; Hoffman GS; Ikle D; Kallenberg CG; Langford CA; Mueller M; Seo P; St Clair EW; Spiera R; Tchao N; Ytterberg SR; Gu YZ; Snyder RD; Merkel PA
    Arthritis Rheum; 2011 Dec; 63(12):3988-97. PubMed ID: 21953143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.
    Berti A; Cavalli G; Campochiaro C; Guglielmi B; Baldissera E; Cappio S; Sabbadini MG; Doglioni C; Dagna L
    Semin Arthritis Rheum; 2015 Aug; 45(1):48-54. PubMed ID: 25841802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes.
    Shi L
    Rheumatol Int; 2017 Nov; 37(11):1779-1788. PubMed ID: 28956128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wallace ZS; Miloslavsky EM; Cascino M; Unizony SH; Lu N; Hoffman GS; Kallenberg CGM; Langford CA; Merkel PA; Monach PA; Seo P; Spiera R; St Clair EW; Specks U; Brunetta P; Choi HK; Stone JH
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1004-1010. PubMed ID: 27696762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile dermatomyositis: novel treatment approaches and outcomes.
    Varnier GC; Pilkington CA; Wedderburn LR
    Curr Opin Rheumatol; 2018 Nov; 30(6):650-654. PubMed ID: 30124602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly.
    Fenoglio R; Roccatello D; Sciascia S
    Kidney Blood Press Res; 2020; 45(6):784-791. PubMed ID: 33045710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: a monocentric prospective study.
    Yoon T; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2019 Jun; 38(6):1685-1690. PubMed ID: 30863949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.